Power Law company profile

NANOLEK

Biotech & Life Sciences · Lovintsy, Russia · Founded 2011 Thoroughbred

Russian biopharmaceutical company having own high-quality full-cycle production in accordance with gmp standards

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on NANOLEK's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage

Rusnano

Global footprint

Where NANOLEK has talent and traffic

Workforce by country

3 countries with
team presence

🇷🇺 Russia95.9%

🇫🇮 Finland2.1%

🇳🇱 Netherlands2.1%

3 countries shown

Web traffic by country

9.1K monthly visits
across markets

🏳️ Russian Federation45.1%

🇺🇸 United States9.9%

Top 2 markets shown

Market sentiment

What the market is saying about NANOLEK

An AI-synthesized read of the highest-engagement posts about NANOLEK on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NANOLEK on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles